Currently, the share price for Beta Drugs Ltd. is delayed. Login to view live prices.
Beta Drugs Ltd.
0.00 (0.00%) 1D
- Prev. Close1,167.90
- Upper Circuit1,401.45
- Lower Circuit934.35
Analyst Recommendations For Beta Drugs Ltd.
As recommended by 1 analyst
Beta Drugs Ltd.'s Info & Management
Beta Drugs is in the midst of developing new drug delivery systems, new dosage formulations and applying the latest technology for better processes. The Research centre is proficient in developing, scaling up and commercializing various dosage forms spread across tablets, capsules, oral liquids and injectables (solutions, suspensions, lyophilized, etc.)
- Chief Financial OfficerMr. Nipun Arora
- Company Secretary,Compliance OfficerRajni Brar
FAQs on Beta Drugs Ltd.
What is the share price of Beta Drugs Ltd.?
Beta Drugs Ltd. share price is ₹0.00 as of January 1, 1970, 05:30 AM. Share prices change over the course of a trading day, and may differ basis on exchange (NSE/BSE).
What is the market cap of Beta Drugs Ltd.?
Market cap is calculated by multiplying the company's share price with the total outstanding shares. The market cap of Beta Drugs Ltd. is ₹1,123 Cr as of November 30, 2023.
What is the PB ratio of Beta Drugs Ltd.?
The trailing twelve month (TTM) PB ratio of Beta Drugs Ltd. is 9.10 as of November 30, 2023. The PB ratio measures the market capitalization of the company relative to it’s book value (carrying value on the balance sheet) as of last reported period.
What are the Upper Circuit and Lower Circuit of Beta Drugs Ltd.?
Upper Circuit is ₹1,401.45. Lower Circuit is ₹934.35.
What is the ROE of Beta Drugs Ltd.?
Beta Drugs Ltd. reported an ROE of 24.99% for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.
What is the shareholding pattern of Beta Drugs Ltd.?
Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Beta Drugs Ltd., Promoter held 66.7%, the FII held 0.3%, and the public held 32.9% of the total shares.
How to buy Beta Drugs Ltd. Share?
What is the fair value of Beta Drugs Ltd.?
Fair value in investing refers to the estimated potential price of the business. The market (or exchange) is expected to determine the fair value of listed companies by the way of demand and supply. To determine the fair value of Beta Drugs Ltd. as per market, look at the current bid and ask prices during the trading hours.
Trademarks owned by their respective owners and shown here only for ease of recall of the respective owner by public.